Although those benefits have been demonstrated only for specific OMMs (that is, tirzepatide for OSAS and semaglutide for KOA), it is plausible that these effects are largely driven by weight reduction rather than by unique pharmacodynamic properties of each molecule 55,56
Instead, it requires a smarter approach that supports your body and lifestyle
Simply put, if your BMI is between 27-30 and you have a weight responsive medical condition (such as high blood pressure, diabetes, GERD, sleep apnea, etc) you meet the medical criteria for anti-obesity medication usage
they are research tools that have generated interesting preclinical data
Well review your goals, health history, and any needed lab work to determine which peptides are right for you
Compounded medication access is described as pharmacy-based, with formulation and dispensing governed outside the platform